212 related articles for article (PubMed ID: 30864712)
1. Estrogen receptor β suppresses inflammation and the progression of prostate cancer.
Xiao L; Luo Y; Tai R; Zhang N
Mol Med Rep; 2019 May; 19(5):3555-3563. PubMed ID: 30864712
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
[TBL] [Abstract][Full Text] [Related]
3. ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1.
Mak P; Li J; Samanta S; Mercurio AM
Oncotarget; 2015 Nov; 6(37):40247-54. PubMed ID: 26450901
[TBL] [Abstract][Full Text] [Related]
4. Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3.
Miao L; Yun X; Tao R; Wang Y; Fan G; Zhu Y; Cai T; Zhu Z; Yan C; Gao X
J Pharmacol Sci; 2018 Sep; 138(1):1-8. PubMed ID: 30236540
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
[TBL] [Abstract][Full Text] [Related]
6. Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway.
Wan CX; Xu M; Huang SH; Wu QQ; Yuan Y; Deng W; Tang QZ
Mol Med Rep; 2018 Feb; 17(2):3085-3091. PubMed ID: 29257294
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells.
Indukuri R; Hases L; Archer A; Williams C
Front Endocrinol (Lausanne); 2021; 12():650625. PubMed ID: 33859619
[TBL] [Abstract][Full Text] [Related]
8. Elemental diet inhibits pro‑inflammatory cytokine production in keratinocytes through the suppression of NF‑κB activation.
Harada K; Ferdous T; Mizukami Y; Mishima K
Oncol Rep; 2018 Jul; 40(1):361-368. PubMed ID: 29767264
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway.
Zhou MQ; Shao L; Wu J; Peng N; Jin LP; Wei GZ; Cheng W; Deng CJ
Mol Med Rep; 2017 Dec; 16(6):8983-8988. PubMed ID: 29039483
[TBL] [Abstract][Full Text] [Related]
10. Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β.
Tao X; Xu L; Yin L; Han X; Qi Y; Xu Y; Song S; Zhao Y; Peng J
Cell Death Dis; 2017 Aug; 8(8):e2989. PubMed ID: 28796245
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer.
Nakamura Y; Felizola SJ; Kurotaki Y; Fujishima F; McNamara KM; Suzuki T; Arai Y; Sasano H
Prostate; 2013 May; 73(6):590-5. PubMed ID: 23060014
[TBL] [Abstract][Full Text] [Related]
12. Silencing of PYGB suppresses growth and promotes the apoptosis of prostate cancer cells via the NF‑κB/Nrf2 signaling pathway.
Wang Z; Han G; Liu Q; Zhang W; Wang J
Mol Med Rep; 2018 Oct; 18(4):3800-3808. PubMed ID: 30106110
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes.
Lv F; Yu Y; Wang G; Hu J; Zhang B; You W; Wang J
Mol Med Rep; 2015 May; 11(5):3753-9. PubMed ID: 25585688
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
[TBL] [Abstract][Full Text] [Related]
15. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
[TBL] [Abstract][Full Text] [Related]
17. Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells.
Silva RS; Lombardi APG; de Souza DS; Vicente CM; Porto CS
Int J Biochem Cell Biol; 2018 Mar; 96():40-50. PubMed ID: 29341930
[TBL] [Abstract][Full Text] [Related]
18. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells.
Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL
Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813
[TBL] [Abstract][Full Text] [Related]
19. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of metformin on lipopolysaccharide‑induced airway epithelial cell injury via NF‑κB signaling inhibition.
Sun J; Huang N; Ma W; Zhou H; Lai K
Mol Med Rep; 2019 Mar; 19(3):1817-1823. PubMed ID: 30628691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
